Judge Lifts Generic Oxandrin Ban

Law360, New York (December 11, 2006, 12:00 AM EST) -- In a surprising setback for Savient Pharmaceuticals Inc., a federal judge has decided to lift a temporary restraining order granted a week earlier to the drug maker that halted the sale of all generic versions of its weight-gain drug Oxandrin.

Judge Peter G. Sheridan ordered to withdraw the ban on generic companies Novartis AG unit Sandoz Pharmaceuticals and Upsher-Smith Laboratories Inc. in the U.S. District Court for the District of New Jersey on Friday.

The temporary restraining order (TRO), which will officially be lifted on Tuesday,...
To view the full article, register now.